Literature DB >> 2222445

The complete nucleotide sequence of the gene coding for botulinum type C1 toxin in the C-ST phage genome.

K Kimura1, N Fujii, K Tsuzuki, T Murakami, T Indoh, N Yokosawa, K Takeshi, B Syuto, K Oguma.   

Abstract

Two DNA fragments, 3 kbp and 7.8kbp, which encode the type C1 botulinum neurotoxin gene, were obtained from toxigenic bacteriophage DNA by treatment with a restriction enzyme. They were cloned into the plasmid vectors for nucleotide sequence determination. The nucleotide sequence contained a single open reading frame coding for 1,291 amino acids corresponding to a polypeptide with a molecular weight of 149,000. The amino acid sequence of the C1 toxin has a few regions highly homologous with tetanus toxin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2222445     DOI: 10.1016/0006-291x(90)90828-b

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

1.  Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization.

Authors:  T J Smith; J Lou; I N Geren; C M Forsyth; R Tsai; S L Laporte; W H Tepp; M Bradshaw; E A Johnson; L A Smith; J D Marks
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Molecular analysis of an extrachromosomal element containing the C2 toxin gene discovered in Clostridium botulinum type C.

Authors:  Yoshihiko Sakaguchi; Tetsuya Hayashi; Yumiko Yamamoto; Keisuke Nakayama; Kai Zhang; Shaobo Ma; Hideyuki Arimitsu; Keiji Oguma
Journal:  J Bacteriol       Date:  2009-03-06       Impact factor: 3.490

Review 3.  Properties and use of botulinum toxin and other microbial neurotoxins in medicine.

Authors:  E J Schantz; E A Johnson
Journal:  Microbiol Rev       Date:  1992-03

4.  The (QxW)3 domain: a flexible lectin scaffold.

Authors:  B Hazes
Journal:  Protein Sci       Date:  1996-08       Impact factor: 6.725

5.  Two different types of ADP-ribosyltransferase C3 from Clostridium botulinum type D lysogenized organisms.

Authors:  K Moriishi; B Syuto; M Saito; K Oguma; N Fujii; N Abe; M Naiki
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

6.  Oral vaccination with an adenovirus-vectored vaccine protects against botulism.

Authors:  Shan Chen; Qingfu Xu; Mingtao Zeng
Journal:  Vaccine       Date:  2013-01-04       Impact factor: 3.641

7.  Pepsin fragmentation of botulinum type E neurotoxin: isolation and characterization of 112, 48, 46, and 16 kD fragments.

Authors:  J A Giménez; B R DasGupta
Journal:  J Protein Chem       Date:  1992-06

8.  Comparative analysis of C3 and botulinal neurotoxin genes and their environment in Clostridium botulinum types C and D.

Authors:  D Hauser; M Gibert; M W Eklund; P Boquet; M R Popoff
Journal:  J Bacteriol       Date:  1993-11       Impact factor: 3.490

9.  Protective immunity against botulism provided by a single dose vaccination with an adenovirus-vectored vaccine.

Authors:  Mingtao Zeng; Qingfu Xu; Md Elias; Michael E Pichichero; Lance L Simpson; Leonard A Smith
Journal:  Vaccine       Date:  2007-09-05       Impact factor: 3.641

10.  Vaccination with recombinant whole heavy chain fragments of Clostridium botulinum Type C and D neurotoxins.

Authors:  Hideyuki Arimitsu; Jae-Chul Lee; Yoshihiko Sakaguchi; Yuji Hayakawa; Michiko Hayashi; Miki Nakaura; Hikaru Takai; Song-Nan Lin; Masafumi Mukamoto; Tom Murphy; Keiji Oguma
Journal:  Clin Diagn Lab Immunol       Date:  2004-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.